Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system
Costs of hospital-associated care for patients with juvenile idiopathic arthritis in the Dutch healthcare system (Wiley).
This study aims to 1) quantify costs of hospital‐associated care for juvenile idiopathic arthritis (JIA), 2) provide insights in patient‐level variation in costs, and 3) investigate costs over time from the moment of JIA diagnosis. Results are reported for all JIA patients in general and by subtype.
Hospital care costs of JIA vary substantially between individuals, between
subtypes, and over the treatment course. The highest annual costs were for
systemic JIA, primarily attributable to medication (i.e. biologicals).
Quelle: Wiley, 02.05.2021